125 related articles for article (PubMed ID: 25108207)
21. Suppressive effect of combination treatment of leflunomide and methotrexate on chemokine expression in patients with rheumatoid arthritis.
Ho CY; Wong CK; Li EK; Tam LS; Lam CW
Clin Exp Immunol; 2003 Jul; 133(1):132-8. PubMed ID: 12823287
[TBL] [Abstract][Full Text] [Related]
22. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.
Kalden JR; Schattenkirchner M; Sörensen H; Emery P; Deighton C; Rozman B; Breedveld F
Arthritis Rheum; 2003 Jun; 48(6):1513-20. PubMed ID: 12794818
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of multiorgan toxicity induced by long term use of disease modifying anti-rheumatic drugs.
Mumtaz T; Tahir A; Tariq MA; Iqbal MA
PLoS One; 2023; 18(8):e0290668. PubMed ID: 37624868
[TBL] [Abstract][Full Text] [Related]
24. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
[TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
[TBL] [Abstract][Full Text] [Related]
27. Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis.
Perez-Ruiz F; Nolla JM
J Clin Rheumatol; 2003 Aug; 9(4):215-8. PubMed ID: 17041461
[TBL] [Abstract][Full Text] [Related]
28. [Experience in long-term therapy of active rheumatoid arthritis with leflunomide].
Chichasova NV; Igolkina EV; Brodetskaia KA; Imametdinova GR
Ter Arkh; 2005; 77(5):33-8. PubMed ID: 15989000
[TBL] [Abstract][Full Text] [Related]
29. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis.
Urano W; Yamanaka H; Tsutani H; Nakajima H; Matsuda Y; Taniguchi A; Hara M; Kamatani N
J Rheumatol; 2002 Sep; 29(9):1950-3. PubMed ID: 12233891
[TBL] [Abstract][Full Text] [Related]
30. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
Ollendorf DA; Peterson AN; Doyle J; Huse DM
Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
[TBL] [Abstract][Full Text] [Related]
31. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Chen Z; Li XP; Li ZJ; Xu L; Li XM
Int Immunopharmacol; 2013 Mar; 15(3):474-7. PubMed ID: 23415907
[TBL] [Abstract][Full Text] [Related]
32. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
[TBL] [Abstract][Full Text] [Related]
33. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
[TBL] [Abstract][Full Text] [Related]
34. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
[TBL] [Abstract][Full Text] [Related]
35. The effect of the systemic inflammatory response, as provoked by elective orthopaedic surgery, on serum uric acid in patients without gout: a prospective study.
Waldron JL; Ashby HL; Razavi C; Thomas OL; Chugh S; Deshpande S; Ford C; Gama R
Rheumatology (Oxford); 2013 Apr; 52(4):676-8. PubMed ID: 23258648
[TBL] [Abstract][Full Text] [Related]
36. Leflunomide for the treatment of rheumatoid arthritis.
Olsen NJ; Strand V; Kremer JM
Bull Rheum Dis; 1999; 48(8):1-4. PubMed ID: 10628065
[TBL] [Abstract][Full Text] [Related]
37. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy and safety of methotrexate + leflunomide in Colombian patients with active rheumatoid arthritis refractory to conventional treatment.
Londono J; Santos AM; Santos PI; Cubidez MF; Guzman C; Valle-Oñate R
Rev Bras Reumatol; 2012 Dec; 52(6):837-45. PubMed ID: 23223695
[TBL] [Abstract][Full Text] [Related]
39. Antimetabolites in the treatment of arthritis: current status of the use of antimetabolites.
Dijkmans BA; Jansen G
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1083-8. PubMed ID: 15571207
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group.
Rozman B
J Rheumatol Suppl; 1998 Jul; 53():27-32. PubMed ID: 9666415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
